Sponsor

Adaptimmune

Clinical research sponsor

Published trials4
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

4 shown
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung CancerNCT06048705 · lead sponsor · 2021-03-09
TERMINATED
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid TumorsNCT04526509 · lead sponsor · 2020-12-21
TERMINATED
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLCNCT02592577 · lead sponsor · 2015-11-01
COMPLETED
Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene TherapyNCT00991224 · collaborator · 2009-11-01
COMPLETED

Sponsor roles

lead sponsor3
collaborator1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.